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Abstract
Background: The accuracy and precision of estimates of DNA concentration are critical factors
for efficient use of DNA samples in high-throughput genotype and sequence analyses. We evaluated
the performance of spectrophotometric (OD) DNA quantification, and compared it to two
fluorometric quantification methods, the PicoGreen® assay (PG), and a novel real-time quantitative
genomic PCR assay (QG) specific to a region at the human BRCA1  locus. Twenty-Two
lymphoblastoid cell line DNA samples with an initial concentration of ~350 ng/uL were diluted to
20 ng/uL. DNA concentration was estimated by OD and further diluted to 5 ng/uL. The
concentrations of multiple aliquots of the final dilution were measured by the OD, QG and PG
methods. The effects of manual and robotic laboratory sample handling procedures on the
estimates of DNA concentration were assessed using variance components analyses.
Results:  The OD method was the DNA quantification method most concordant with the
reference sample among the three methods evaluated. A large fraction of the total variance for all
three methods (36.0–95.7%) was explained by sample-to-sample variation, whereas the amount of
variance attributable to sample handling was small (0.8–17.5%). Residual error (3.2–59.4%),
corresponding to un-modelled factors, contributed a greater extent to the total variation than the
sample handling procedures.
Conclusion: The application of a specific DNA quantification method to a particular molecular
genetic laboratory protocol must take into account the accuracy and precision of the specific
method, as well as the requirements of the experimental workflow with respect to sample volumes
and throughput. While OD was the most concordant and precise DNA quantification method in
this study, the information provided by the quantitative PCR assay regarding the suitability of DNA
samples for PCR may be an essential factor for some protocols, despite the decreased concordance
and precision of this method.
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Background
Molecular genetic studies hold the promise of identifying
genetic factors that influence human disease susceptibility
and outcome [1]. However, large sample sizes are
required to find small to moderate sized genetic effects in
association studies [2]. Technical advances in genotype
and sequence analysis, together with essentially unlimited
availability of sequence and sequence variation informa-
tion, have substantially increased the scope of human
genetic studies. It is now possible to examine many poly-
morphisms or sequences in high-throughput settings,
using significantly less DNA per assay (~1–5 ng) than in
the past decade. Nevertheless, conservation of precious
DNA samples represents a critical goal for the efficient uti-
lization of research resources. One area of technological
development essential for success in high-throughput
genotyping is the quantification of DNA. Accurate and
precise DNA quantification is necessary for efficient high-
throughput genotyping and sample conservation. Inaccu-
racy in quantification of DNA results in the unnecessary
consumption of DNA. Imprecise quantification increases
variability in the amount of PCR product used by most
genotyping technologies, leading to lower confidence in
scoring of genotypes [3,4]. Inaccuracies in quantification
of DNA samples that will constitute a pool of DNA lead to
inaccurate allele frequency estimations [5]. Conservation
of the original DNA samples is important to validate pre-
vious findings and to allow for future studies, even if
whole genome amplification technologies prove to be
accurate and reliable [6,7].
Until recently, UV absorbance spectroscopy has been the
traditional method of quantifying DNA in molecular biol-
ogy laboratories prior to molecular genetic analyses [8,9].
Quantification of genomic DNA using intercalating fluor-
ochromes [10,11] and oligonucleotide hybridization
methods [12] has decreased DNA consumption due to the
increased sensitivity of these methods and has increased
laboratory efficiency due to the high-throughput format
of fluorometers. We assessed the performance of three
DNA quantification methods and give recommendations
for their use in facilities processing biospecimens for gen-
otyping and sequencing analyses. These three methods
are: 1) UV absorbance spectroscopy, referred to here as the
OD method, 2) the detection of fluorescent signal
enhancement of PicoGreen® dsDNA Quantitation Reagent
which selectively binds to dsDNA [10,13], referred to here
as the PG method, and 3) the detection of fluorescent sig-
nal from a 5' exonuclease assay [14], referred to here as the
quantitative genomic or QG method.
First, we performed a high-throughput laboratory sample
handling workflow using 22 high-quality DNA samples at
concentrations typical of DNA extracted from lym-
phocytes. Sample-handling procedures diluted the DNA
to two concentrations commonly used for normalization
prior to genotyping. Three methods were used to estimate
the DNA concentration of the aliquots producing a total
of 14,784 concentration estimates. Variance components
analysis was used to assess the influence of these sample-
handling steps on performance of the three DNA quanti-
fication methods.
Results
Table 1 shows the summary statistics for the concentra-
tion estimates and Figure 1 presents the distributions of
DNA concentration estimates for the OD-U, OD-D, QG
and PG methods. The mean DNA concentration estimate
for the OD-U evaluation, 20.57 ng/uL, was significantly
higher than the expected value of 20.00 ng/uL (p-value for
the t-test for the mean <0.0001); however, the distribu-
tion of the concentration estimates was negatively skewed
(skewness coefficient = -0.12) due to several DNA concen-
tration estimates in the 17–18 ng/uL range (Table 1 and
Figure 1a). The expected DNA concentration estimate for
OD-D, QG, and PG is 5.14 ng/uL, one-fourth of the
observed OD-U estimate of 20.57 ng/uL, due to the dilu-
tion step (See Figure 2). The mean OD-D concentration
estimate of 5.13 ng/uL was close to the expected value (p
< 0.5464), while the distribution of the concentration
estimates was positively skewed (skewness coefficient =
0.25) (Table 1 and Figure 1b). The observed mean for QG,
5.98 ng/uL, showed the largest deviation from the
expected value, (p < 0.0001), and the distribution of the
values was negatively skewed (skewness coefficient = -
0.75), due primarily to a number of QG reactions (0.2%
of the total) that failed to amplify and gave zero values
(Table 1 and Figure 1c). The PG method also resulted in a
mean concentration, 5.21 ng/uL, that was significantly
greater than the expected value (p < 0.0148), and the con-
centration estimates were also negatively skewed (skew-
ness coefficient = -0.52) due to several low, but non-zero
concentration estimates (Table 1 and Figure 1d).
The CVs and their 95% CIs were low for all methods
(Table 1). The CV for the OD-U method, 8.0%, was statis-
tically significantly lower than the CVs for the other three
methods, and the CV for the OD-D method, 10.3%, was
statistically significantly lower than the CVs for the QG
(13.8%) and PG (13.6%) concentration estimates, which
were not statistically significantly different from each
other.
Variance contributions of the individual samples, labora-
tory sample handling for each of the three DNA quantifi-
cation methods were obtained using variance
components analysis. The results are given in Table 2.
Overall, the OD methods had the smallest total variance,
and the fluorometric methods had the largest. The percent
error attributable to sample variability was greatest for theBMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/20
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20 ng/uL dilution of DNA in the OD-U method (95.7%),
and much less for the methods that had the additional 5
ng/uL dilution of DNA (36.0–60.0%), though the abso-
lute amount of error attributable to sample variability was
significantly greater for the fluorometric methods than for
the OD methods. The contribution to the total variance
from assay aliquot or dilution was less than 5% for all
three methods. The variance contribution of OD Aliquot
was substantial for OD-D (12.8%), but less than 3% for
all the other methods. The error due to repeated OD read-
ings of the same DNA sample in the same well was esti-
mated to be zero. The amount of variance attributable to
the entire laboratory sample handling procedure was larg-
est in the OD-D method (17.5%) and smallest in the PG
method (4.3%). The variance attributable to the OD Aliq-
uot step in the OD-D method (12.8%) was significantly
larger than any other error component attributable to lab-
oratory sample handling procedures. Residual error
accounted for a larger proportion of variance in the fluor-
ometric methods (36–59.4%) than in the OD methods
(3.2–22.8%).
Discussion
Accurate and precise quantification of DNA is critical for
efficient genotyping, particularly in a high-throughput
setting, in order to maximize completion rates, accuracy
and reproducibility. Accurate quantification of DNA ena-
bles prudent management of DNA samples. Precise quan-
tification of DNA reduces the variance of fluorescent
signal derived from high-throughput genotyping technol-
ogies and increases the confidence in scoring genotypes.
We have compared the performance of three different
DNA quantification methods widely used in bioreposi-
tory and genotyping facilities. The optical density of DNA
(260/280 nm), the most popular approach to estimate
DNA concentrations, was assessed at two different DNA
concentrations (20 ng/uL and 5 ng/uL) commonly used
for normalization of DNA prior to genotyping workflows.
The fluorometric methods that we assessed were
PicoGreen®, which fluoresces when bound to dsDNA, and
the QG method, based on the TaqMan® assay. The OD-D
(5 ng/uL) method was the least biased method, and the
OD-U (20 ng/uL) method was the most precise method.
The QG method was the most biased method, and both
fluorometric methods were less precise than the OD
methods evaluated. Thus, absorbance spectrophotometry
of DNA appears to be less biased than the more complex
fluorometric methods that rely upon multiple interacting
components and more indirect measurements of DNA
concentration. However, the experimental design used to
test the methods may have influenced the apparent rela-
tionship between the complexity and the performance of
the method. Specifically, the more complex fluorometric
methods were evaluated after a larger number of labora-
tory sample handling steps and the volumes used are
inversely related to the complexity of the DNA quantifica-
tion assays.
Sample-to-sample variability was the single largest factor
that contributed to the error in estimated DNA concentra-
tions, while laboratory sample handling steps and resid-
ual (unmodeled) factors had a lesser impact, as assessed
by variance components (Table 2). DNA sample prepara-
tion can be difficult to control in some large-scale studies;
thus, genotyping facilities receiving DNA samples from
multiple studies should expect DNA sample variability to
be a major factor affecting sample-processing throughput.
Reassuringly, the estimated residual variance was minimal
in the quantification method with the smallest number of
sample handling steps (OD-U). The residual variance was
greatest in the fluorometric methods, perhaps because the
greater complexity and reduced reproducibility of these
assays. The relationship between aliquot volume and
sample variability also suggests that smaller volumes, e.g.,
Table 1: Descriptive statistics for the three DNA quantification methods (four evaluations)
Evaluation 
Type
N Obs. Mean 
[ng/uL]
Std. Dev. 
[ng/uL]
Exp. Mean 
[ng/uL]
P-value CV (%) 
(95% CI)
Min. Value 
[ng/uL]
Max. Value 
[ng/uL]
Skewness
OD-U 704 20.57 1.64 20.00 < 0.0001* 8.0
(0.079, 
0.080)
17.17 24.41 - 0.12
OD-D 2816 5.13 0.53 5.14 0.5464 10.3
(0.097, 
0.109)
3.63 8.26 0.25
QG 5632 5.98 0.83 5.14 < 0.0001* 13.8
(0.129, 
0.146)
0.00 11.41 - 0.75
PG 5632 5.21 0.71 5.14 0.0148* 13.6
(0.129, 
0.143)
0.19 7.95 - 0.59BMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/20
Page 4 of 10
(page number not for citation purposes)
the 2.0 uL and 5.0 uL of DNA sample used in the QG and
PG methods, respectively, introduce more sample varia-
bility, perhaps due to sampling effects or increased failure
to transfer small volumes.
Spectrophotometric determination of DNA concentration
provided at high concentration by the biorepository,
using one or two dilution steps, each step associated with
the estimation of concentration via OD, was the least
biased and exhibited the smallest total variance in this
study. Thus, quantification workflows that consist of only
one OD measurement of one aliquot after DNA extraction
and then aliquoting or normalization to the nominal con-
centration used in a genotyping or sequencing assay are
likely to be significantly more inaccurate than the proto-
col followed in this study. Other advantages of the OD
method are that spectrophotometers are more widely
available than the fluorometric laboratory equipment
required for the QG and PG methods and that the OD
estimation of DNA concentration can be performed
Distribution of DNA concentration estimates [ng/uL] for the three quantification methods (four evaluations) Figure 1
Distribution of DNA concentration estimates [ng/uL] for the three quantification methods (four evaluations). The estimates 
are standardized by dividing the counts by the total number of observations for each of the four evaluations. Figure 1a; Distri-
bution of DNA concentration estimates [20 ng/uL] for OD-U (N = 704 observations). Figure 1b, 1c and 1d; Distribution of 
DNA concentration estimates [5 ng/uL] for OD-D (N = 2816), QG (N = 5632), and PG (N = 5632), respectively.BMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/20
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Experimental Workflow Figure 2
Experimental Workflow. Flowchart shows sample-handling processes (dilutions and aliquots, depicted by arrows) for a single 
DNA sample (right). Total DNA concentration estimates collected for all samples (N = 22) for each method (four evaluations) 
is shown at left.
Table 2: Variance component estimates (standard error in parenthesis) for the three DNA quantification methods (four evaluations).
Variance 
Component
N (Replicates) OD-U OD-D QG PG
Sample 22 0.0064 (0.002) 0.0067 (0.0021) 0.0110 (0.0034) 0.0130 (0.004)
% of Total Variance 95.7% 60.0% 55.0% 36.0%
OD Aliquot 4 0.0000 (0) 0.0014 (0.0013) 0.0005 (0.0005) 0 (0)
% of Total Variance 0.8% 12.8% 2.3% 0.0%
Dilution 4 N/A 0.0005 (0.0002) 0.0004 (0.0002) 0.0011 (0.0004)
% of Total Variance Nested w/ OD Aliq. 4.7% 1.8% 3.2%
Assay Aliquot 16 N/A N/A 0.0010 (0.0001) 0.0004 (0.0001)
% of Total Variance 4.8% 1.1%
Run 8 0.0000 (0) 0 (0) N/A N/A
% of Total Variance 0.0% 0.0%
Residual Error - 0.0002 (0) 0.0025 (0.0001) 0.0072 (0.0001) 0.0212 (0.0004)
% of Total Variance 3.2% 22.8% 36.0% 59.4%
Total Variance - 0.0066 0.0111 0.0201 0.0357
OD-U 1
20.0 ng/uL (150 uL)
OD-U 2
20.0 ng/uL (150 uL)
OD-D 1-4
5.0 ng/uL (150 uL)
OD-D 13-16
5.0 ng/uL (150 uL)
OD-D 9-12
5.0 ng/uL (150 uL)
OD-D 5-8
5.0 ng/uL (150 uL)
OD-U 4
20.0 ng/uL (150 uL)
OD-U 3
20.0 ng/uL (150 uL)
1:4 Dilution (4X)
Method:  OD-Undiluted (OD-U)
N (Total):  704
Method:  OD-Diluted (OD-D)
N (Total):  2816
Dilution
QG
2.0 uL
Aliquot
PG
5.0 uL
Aliquot
1:4 Dilution (4X) 1:4 Dilution (4X) 1:4 Dilution (4X)
Assay Aliquot (16X)
QG
2.0 uL
Aliquot
PG
5.0 uL
Aliquot
QG
2.0 uL
Aliquot
PG
5.0 uL
Aliquot
QG
2.0 uL
Aliquot
PG
5.0 uL
Aliquot
Dilution
OD Aliquot 1 OD Aliquot 2 OD Aliquot 3 OD Aliquot 4
Diluted DNA Sample
20.0 ng/uL (1000.0 uL)
Concentrated DNA Sample
(N=22)
~ 350 ng/uL
Assay Aliquot (16X) Assay Aliquot (16X) Assay Aliquot (16X)
Method: QG
2.0 uL Aliquot
N (Total): 5632
Method: PG
5.0 uL Aliquot
N (Total): 5632
Assay Aliquot
OD Aliquot
Data Points Collected
Diluted DNA Sample
20.0 ng/uL (1000.0 uL)BMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/20
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without consuming the sample, additional reagents or
incubation time. In contrast, the QG and PG methods
require more specialized optical equipment, consume
DNA samples, and are dependent upon reagents and a
reaction timeline that is measured in minutes to hours.
QG requires a labeled oligonucleotide, Taq DNA polymer-
ase, deoxynucleotides, buffer, a sophisticated detection
instrument, and ~two hours. The additional complexity of
the QG and PG methods suggest that the OD method is
preferred over the QG and PG methods.
Despite these advantages of the OD method, there are dis-
advantages compared to the fluorometric methods. Large
amounts of DNA are necessary for spectrophotometric
analysis in current instrumentation for high-throughput
environments. In the OD methods used in this study, the
minimum amount and volume of DNA evaluated was
750 ng in 150 uL. Thus, fluorometric determination of
DNA concentration may be preferred over the OD
method in high-throughput environments principally
due to the lower quantity of DNA needed. Proteins, RNA,
and salts, all of which are contaminants of DNA extracted
from various biological sources, can increase the spectro-
photometric estimation of DNA concentration. In addi-
tion, the OD method cannot distinguish between ssDNA
and dsDNA in solution as can the PG method, which does
not bind to ssDNA [13] or between DNA from the species
of interest (in our study human DNA) and other poten-
tially contaminating sources of DNA, for example, bacte-
rial DNA, as can the QG method. The ability of a DNA
sample to successfully amplify via PCR is an indication of
the quality of the DNA sample, and this information is
provided only by the QG method. Thus, the OD method
has limitations that may contribute to inaccuracy of DNA
concentration estimates and it may not be sufficiently sen-
sitive for some high-throughput environments, especially
those working with limited or potentially contaminated
DNA samples, such as forensic samples or some popula-
tion-based collections.
Rengarajan et al. have evaluated the sensitivity and linear-
ity of four fluorochromes (ethidium bromide, Hoechst
33258, SYBR® Green I and PicoGreen®) commonly used
for DNA quantification [15]. They demonstrate that ethid-
ium bromide and Hoechst 33258 are suitable for estimat-
ing DNA concentration in the range of ~200 ng/mL to 20
ug/mL and that SYBR® Green I and PicoGreen® are suitable
for estimating DNA concentration in the range of 0.2 ng/
mL to 20 ug/mL. The intra-assay CV (between replicates)
of PicoGreen® was stated to be 8.3%, where the intra-assay
CV of PicoGreen® in this study was found to be 13.6%,
which is comparable to their findings. In this study, how-
ever, we are evaluating the bias of DNA quantification
methods, not the sensitivity of DNA quantification
methods.
Real-time PCR assays are commonly used to detect small
changes in gene copy-number and expression, and the ref-
erence values used in those applications are often in the
femtogram and picograms ranges [16], and use standard
curves based on a log-scale. In this study, however, the QG
method was used to determine quantity of DNA, and the
5.0 ng/uL concentration was chosen to be indicative of
values commonly seen in high-throughput laboratories,
such as a biorepository. Therefore, a linear standard curve
range (1.0 to 10.0 ng/uL) was chosen, and the assay's
repeatability was high, with the CV of the R2-value of the
standard curve for QG method only 0.22%, and only
0.14% for the PG method. Although SYBR® Green I has
been used to detect dsDNA product during PCR [17], it
has been previously shown that the greatest specificity is
achieved with probe hybridization [18], as used in this
study with the QG method. Although the use of SYBR®
Green I is also suitable for dsDNA quantification, Molec-
ular Probes Inc., the manufacturer of both dyes, claims
that PicoGreen® is more linear than SYBR® Green I in the
range of 10 pg/uL to 1 ug/uL (personal communication).
This linearity had been addressed in Renegarajan, et al.,
with the linearity of PicoGreen® (0.9737) slightly higher
than for SYBR® Green I (0.9623).
The insensitivity of the OD and PG methods to potential
contaminants of DNA solutions and the sequence specifi-
city and functional information that the QG method pro-
vides may outweigh the increased inaccuracy and reduced
precision seen in this analysis of the QG method for some
practical applications. The choice of DNA quantification
methods to be used by a particular laboratory should be
guided by an understanding of the accuracy, precision and
potential sources of error of those methods, and the prac-
tical aspects of implementing a particular DNA quantifica-
tion method for a particular DNA sample processing or
genotyping application.
Conclusions
We have evaluated bias, variance, and variance compo-
nents associated with three common methods of DNA
quantification in a high-throughput setting. Although the
spectrophotometric method was the most accurate and
precise quantification method evaluated in this study, the
functional information obtained from the real-time PCR
assay provides human specific data on the quantity and
quality of the DNA sample. Sample-to-sample variability
accounted for the majority of quantification error for all
three methods, whereas the variance associated with sam-
ple handling procedures was minimal. High-throughput
laboratories and biorepositories should be aware of the
sources of error in sample handling procedures and
quantification methods to ensure high completion and
low inaccuracy rates in genotyping workflows.BMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/20
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Methods
DNA samples
22 DNA samples were obtained from Coriell Cell Reposi-
tories (Camden, NJ, USA). These samples were extracted
from cell lines using standard high salt procedures [19]
and resuspended by the repository in 10 mM Tris-1 mM
EDTA, pH = 8.0. The samples were provided at high con-
centrations (Mean: 350.0 ng/uL; σ: 28.6 ng/uL; Range:
244.0 – 375.0 ng/uL), as determined by the repository
using optical density (OD260 and OD280).
Instruments
OD measurements were obtained using a SpectraMax
Gemini Plus spectrophotometer, hereafter "Spectropho-
tometer" (Molecular Devices Corp., Sunnyvale, CA, USA).
The spectrophotometer was calibrated at the Core Geno-
typing Facility (CGF) according to manufacturer's proto-
cols using the SPECTRAtest Validation Package for
Microplate Spectrophotometers (Molecular Devices
Corp., Sunnyvale, CA, USA). This validation plate con-
tains a series of National Institutes of Standards and Tech-
nology (NIST)-traceable filters. Eight aspects of the
spectrophotometer were calibrated: 1) baseline noise, 2)
ultimate dark, 3) optical alignment, 4) absorbance accu-
racy, 5) absorbance precision, 6) stray light, 7) wavelength
accuracy, and 8) wavelength precision. QG was performed
on an ABI 7900HT Sequence Detector System, hereafter
"ABI 7900" (Applied Biosystems, Inc., Foster City, CA,
USA). The ABI 7900 was calibrated at the CGF according
to manufacturer's protocol using the Sequence Detection
Systems 384-well Spectral Calibration Kit (Applied Bio-
systems, Inc., Foster City, CA, USA). Enhancement of
PicoGreen® fluorescence was measured on a Fluoroskan
Acent FL, hereafter "Fluorometer" (Thermo LabSystems,
Franklin, MA, USA). The fluorometer was calibrated at the
CGF according to the manufacturer's protocol. Addition
of QG reaction mix was done using a Multimek 96 Auto-
mated 96-channel pipettor, hereafter "Multimek 96"
(Beckman Coulter, Fullerton, CA, USA). Aliquots for QG
and PG assays were dispensed using a Hydra 96 liquid
handling system, hereafter "Hydra" (Robbins Scientific
Corp., Sunnyvale, CA, USA). All aliquots, dilutions, and
assay plates (Figure 2) were prepared in 96-well plates,
with the exception of QG, which was performed in 384-
well plates. All liquid handling systems and manual
pipettes were calibrated according to the manufacturer's
recommendations.
Optical Density Assay (OD)
The Optical Density assay (OD) was tested at two concen-
trations, 20 ng/uL and 5 ng/uL (Figure 2). According to
the biorepository's supplied OD estimation of DNA con-
centration, a 20.0 ug aliquot of each DNA sample was
manually diluted to a nominal 20 ng/uL (1000 uL). Four
150.0 uL "OD Undiluted" aliquots (OD-U) at ~20 ng/uL
(~3.0 ug) were removed and the OD (260, 280, and 325
nm) was determined using a Spectrophotometer. Eight
OD readings ("Run") were obtained for each of the four
aliquots for each sample, resulting in a total of 704 data
points. From each of the four OD-U aliquots, four 37.5 uL
"OD Diluted" aliquots (OD-D) were manually removed
and diluted 1:4 to ~5 ng/uL (~750 ng) using the OD read-
ings determined in this laboratory at the "Run" step. Eight
OD readings were obtained from each OD-D dilution, for
a total of 2816 data points. To calculate DNA concentra-
tion, OD absorbance values (A°260) were multiplied by
50, assuming 1.0 A° = 50.0 ng/uL dsDNA.
Quantitative Genomic PCR Assay (QG)
A real-time PCR assay was developed to quantify human
genomic DNA using a non-polymorphic region of the
human BRCA1 locus. Primers were empirically chosen by
testing three primer pairs for each probe with a serial dilu-
tion of human genomic DNA, quantified multiple times
by OD spectrophotometry, to determine the combination
that resulted in the highest R2 value (typically > 0.99)
when plotting the logarithm (input DNA) versus the
threshold cycle. The best primer pair/probe combination
was then tested against 100 ng of genomic DNA from S.
mutans, S. cerevesiae, mouse, dog, chicken, cat, and bovine
as input, none of which gave signal that was above back-
ground after 40 cycles. According to BLAST [20], the
amplicon was found not to be similar to any regions other
than  BRCA1  [3 × 10-60 versus 0.33 as the next lowest
Expect (E) value in the human genome (Build 30)]. A 119
bp region at the BRCA1 region (IVS11+126) was ampli-
fied using the forward primer 
5'-AAACATGTTCCTCCTAAGGTGCTTT-3', and the reverse
primer 
5'-ATGAAACCAGAAGTAAGTCCACCAGT-3'. Detection
of this amplicon is achieved by a 41-bp labeled oligonu-
cleotide probe, 
5'-FAM-CCTTCACACAGCTAGGACGTCATCTTT-TAM-3'.
From each of the 16 OD-D aliquots, 16 2.0 uL "Assay Aliq-
uots" (~10 ng) were robotically transferred using a Hydra
to 384-well plates and subjected to quantification using
the QG method (Figure 2 and Standard DNA Prepara-
tion). Prior to QG, water was removed from the 2.0 uL
DNA "Assay Aliquots" overnight in a desiccator. Reaction
conditions for QG are as follows: 400 nM primers, 50 nM
probe, 1X Universal Master Mix (Applied Biosystems Inc.,
Foster City, CA, USA), q.s. with water to a final reaction
volume of 5.0 uL. Reactions were cycled on ABI 7900 with
the following cycle conditions: 50°C for 2', 95°C for 10',
followed by 40 cycles of 95°C for 30" and 60°C for 1'. QG
reactions were cycled using the "Absolute Quantification"
assay setting on the instrument. Data was analyzed using
Sequence Detection Software 2.0 (Applied Biosystems
Inc., Foster City, CA, USA), with "Automatic Ct (CycleBMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/20
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Threshold) Determination" enabled with a minimum
quality score of 5 (out of 10).
PicoGreen® Assay (PG)
From the each of the OD-D aliquots, 16 5.0 uL "Assay
Aliquots" (~25 ng) were robotically transferred using a
Hydra to 96-well microplates and subjected to quantifica-
tion using the PG method (Figure 2 and Standard DNA
Preparation). Fluorescence of PicoGreen® was detected
using a Fluorometer, where 95.0 uL of 1X PicoGreen® Rea-
gent, diluted in 1X TE Buffer, was robotically dispensed by
the Fluorometer into 5.0 uL of sample. Samples were
incubated in darkness for 5 minutes, and then excited
(485 nm) and emission measured (520 nm).
Standard DNA Preparation
QG and PG methods of DNA quantification require the
use of a standard curve derived from DNA samples of
known concentrations and an experimentally derived
cycle threshold (Ct) value, for QG, and raw fluorescence
unit (RFU) values, for PG. A DNA sample was obtained
from Coriell Cell Repositories and used to generate a set
of known DNA concentrations (Figure 3). According to
the biorepository's concentration estimate, a 20.0 ug aliq-
uot was diluted to 20.0 ng/uL, and the OD of 100.0 uL
aliquots (N = 10) were determined using a spectropho-
tometer ("OD-STD-20"; Mean: 21.10 ng/uL; σ: 1.33 ng/
uL; Range: 19.20 – 23.26 ng/uL). Based on the measured
OD260 values, each of the ten aliquots was diluted with
water to 12.0 ng/uL, combined into a single solution and
homogenized by vortexing. 100.0 uL aliquots (N = 19)
were removed and OD determined ("OD-STD-12"; Mean:
11.65 ng/uL, σ: 0.49 ng/uL, Range: 10.90 – 12.84 ng/uL).
According to the measured OD260 values, each of the 19
aliquots was further diluted with water to 10.0 ng/uL. All
aliquots were combined into a single solution and
homogenized by vortexing. 100.0 uL aliquots (N = 21)
were removed and OD determined ("OD-STD-10"; Mean:
10.041 ng/uL, σ: 0.46 ng/uL, Range: 9.43 – 11.08 ng/uL).
All 21 aliquots were combined into a single solution and
homogenized by vortexing.
The "OD-STD-10" was used to generate a set of standard
solutions at 1.0, 2.0, 4.0, 5.0, 6.0, 8.0, and 10.0 ng/uL for
QG and PG quantification. Four aliquots from each of the
seven standard solutions comprised a single standard
curve consisting of 28 data points. For every four QG and
PG assay aliquots quantified, one standard curve was pre-
pared and used to determine DNA concentration values.
In total, 16 standard curves were generated for each
method (total N = 32), resulting in 448 data points col-
lected from the standard curves for each method (total N
= 896). Mean R2-value for QG was 0.995 (σ: 0.002, CV:
0.22%), and 0.998 (σ: 0.001, CV: 0.14%) for PG. The
mean Ct value for the QG method was 0.0987 (σ: 0.016,
CV: 16.21%). For QG, the slope of the standard curve is
indicative of the efficiency of the assay. At 100% effi-
ciency, a reaction should achieve a slope of -3.33, since
every 10-fold difference in quantity translates to a differ-
ence on 3.33 Ct's (ABI 7900HT Sequence Detection Sys-
tem, User Guide). The mean slope for QG was -3.836 (σ:
0.087).
Database Design
In order to track the multiple aliquots and dilutions of
each DNA sample used in this study, a Microsoft® Access
database was created. The database schema allows the
import of concentration estimates generated from each of
the quantification platforms. The plate name and well
position provided in the instruments' output file identi-
fied the sample and from which dilutions and/or aliquots
it originated. For the QG and PG methods, the database
also contained the raw values (Ct and RFU) of each of the
standard DNA data points used in determining the DNA
concentration.
Statistical Analysis
We calculated descriptive statistics for the measurements,
including means, standard deviations, the coefficient of
variation (CV) and its 95% confidence interval (CI), and
tested if the mean amount for each method was equal to
its expected value using t-tests. We estimated the compo-
nents of variance attributable to various steps in the sam-
ple handling for each method. For the variance
components analysis, measurements were analyzed on
the natural logarithmic scale, to reduce the dependence of
the SD of the response in the mean. This allowed the
assumption that the total variance of the mean was unre-
lated to individual sample concentration (see Cook and
Weisberg, "Applied Regression Including Computing and
Graphics" Wiley Series in Probability and Statistics. 1999,
page 317). For each method, a nested component of vari-
ance analysis was performed using the restricted maxi-
mum likelihood approach (PROC VARCOMP, SAS 8.0,
SAS/Stat User's Guide, Version 8. SAS Institute Inc.: Cary,
NC, USA, 1999). Restricted maximum likelihood esti-
mates agree with the usual analysis of variance (ANOVA)
estimates when all estimates are greater than zero. Com-
ponents were estimated for "Sample", "OD Aliquot",
"Dilution", "Assay Aliquot", and "Run" (Figure 2). The
general statistical model was written:
Log(zijkl) = µ + ai + bj(i) + ck(ij) + dl(ijk) + εm(ijkl),
with zijkl denoting the amount of DNA for sample i (i = 1,
..., 22). In this model, µ was the mean DNA concentration
and ai, bj(i), ck(ij), dl(ijk) and εm(ijkl) were normally distrib-
uted random variables with mean zero and variances σ2 
a,
σ2 
b, σ2 
c, σ2 
d and σ2 
e, respectively. For OD-U, the model
reduced to:BMC Biotechnology 2003, 3 http://www.biomedcentral.com/1472-6750/3/20
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Log(zijkl) = µ + ai + bj(i) + ck(ij) + εl(ijk),
with the variance component σ2 
a corresponding to "Sam-
ple", σ2 
b to "OD Aliquot" and σ2 
c to "Run". For PG and
QG, the variance component σ2 
a corresponded to "Sam-
ple", σ2 
bto "OD Aliquot", σ2 
c to "Dilution", and σ2 
d to
"Assay Aliquot". For OD-D, σ2 
a corresponded to "Sam-
ple", σ2 
b to "OD Aliquot", σ2 
c to "Dilution" and σ2 
d to
"Run". For all methods, σ2 
e represented all sources of var-
iance that are not specified in the model.
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Creation of a standard set of DNA solutions Figure 3
Creation of a standard set of DNA solutions. OD methods were used to determine the DNA concentration of a standard 
DNA solution that was subsequently used for QG and PG quantification methods.
Concentrated DNA Sample
~ 350 ng/uL
Diluted DNA Sample
20.00 ng/uL (1000.0 uL)
OD-STD-20
N=10 aliquots (100 uL)
Mean: 21.10 ng/uL
Std. Dev.: 1.33 ng/uL
OD-STD-12
N=19 aliquots (100 uL)
Mean: 11.65 ng/uL
Std. Dev.: 0.49 ng/uL
Aliquots (N=10) diluted with water
to 12.00  ng/u, combined into a
single tube, and homogenized
Aliquots (N=19) diluted with water
to 10.00  ng/uL, combined into a
single tube, and homogenized
OD-STD-10
N=21 aliquots (100 uL)
Mean: 10.04 ng/uL
Std. Dev.: 0.46 ng/uL
Standard DNA Solution Set
N=7 DNA Concentrations
1.0, 2.0, 4.0, 5.0,
6.0, 8.0, 10.0 ng/uL
QG
For every four QG Assay Aliquots
(2.0 uL), one standard curve was
generated (N=4 replicates of each
concentration, total N=28)
Raw data values Cycle Threshold
Values (Ct)
PG
For every four PG Assay Aliquots
(5.0 uL), one standard curve was
generated (N=4 replicates of each
concentration, total N=28)
Raw data values Raw Fluorescence
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